Democrats are having trouble uniting behind one plan to lower drug prices. Some Democrats are pushing legislation that would punish pharma companies that refuse to negotiate prices with the federal government, while others are looking to go easier on the industry. (The Hill)

MM&M has unveiled the Hall of Femme class of 2019. Sixteen women leaders have joined the esteemed group after leaving their own indelible mark on the medical, marketing and media industry. (MM&M)

Entrée Health has won the first MM&M Madness tournament. The New York-based shop is cutting down the nets after beating out 31 other firms for bragging rights for the most creative agency name. (MM&M)

Texas and California have moved to legalize CBD in food and drinks. The FDA prohibits putting cannabidiol, a cannabis product, into food and drink products, forcing many companies to pull items containing CBD or simply sell them illegally. Lawmakers in both states want to sidestep that rule and allow these products to be sold. (Associated Press)

A string of digital health IPOs is poised to kick off, led by Livongo, Change Healthcare and Health Catalyst. Livongo, which creates products for people with chronic conditions, has reportedly hired investment banks for an upcoming market debut. The companies could lead a wave of digital health IPOs as early investors look for returns. (CNBC)